AZN vs. DXT.TO
AZN (AstraZeneca PLC) and DXT.TO (Dexterra Group Inc.) are both stocks. AZN operates in Drug Manufacturers - General (Healthcare), while DXT.TO operates in Specialty Business Services (Industrials). Over the past 10 years, AZN returned 15.97%/yr vs 6.75%/yr for DXT.TO. At a 0.11 correlation, their price movements are largely independent.
Performance
AZN vs. DXT.TO - Performance Comparison
Loading charts...
Different Trading Currencies
AZN is traded in USD, while DXT.TO is traded in CAD. To make them comparable, the DXT.TO values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, AZN achieves a 1.85% return, which is significantly lower than DXT.TO's 10.78% return. Over the past 10 years, AZN has outperformed DXT.TO with an annualized return of 15.97%, while DXT.TO has yielded a comparatively lower 6.75% annualized return.
AZN
- 1D
- 1.04%
- 1M
- 0.32%
- YTD
- 1.85%
- 6M
- 4.25%
- 1Y
- 29.14%
- 3Y*
- 9.91%
- 5Y*
- 11.83%
- 10Y*
- 15.97%
DXT.TO
- 1D
- 1.20%
- 1M
- 1.55%
- YTD
- 10.78%
- 6M
- 9.66%
- 1Y
- 48.52%
- 3Y*
- 37.24%
- 5Y*
- 18.72%
- 10Y*
- 6.75%
AZN vs. DXT.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AZN AstraZeneca PLC | 1.85% | 43.30% | -0.62% | 1.44% | 19.14% | 19.66% | 3.12% | 35.68% | 13.86% | 33.10% |
DXT.TO Dexterra Group Inc. | 10.78% | 62.75% | 32.02% | 13.76% | -35.79% | 38.43% | 11.03% | -27.91% | 8.60% | -14.82% |
Correlation
The correlation between AZN and DXT.TO is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.08 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Jul 26, 2006 | 0.11 |
Fundamentals
AZN:
$286.33B
DXT.TO:
CA$829.70M
AZN:
$6.66
DXT.TO:
CA$0.72
AZN:
27.56
DXT.TO:
18.08
AZN:
0.04
DXT.TO:
0.11
AZN:
4.74
DXT.TO:
0.76
AZN:
6.05
DXT.TO:
2.85
AZN:
$60.44B
DXT.TO:
CA$1.08B
AZN:
$49.37B
DXT.TO:
CA$161.12M
AZN:
$20.47B
DXT.TO:
CA$113.74M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AZN vs. DXT.TO — Risk / Return Rank
AZN
DXT.TO
AZN vs. DXT.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AstraZeneca PLC (AZN) and Dexterra Group Inc. (DXT.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AZN | DXT.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.76 | ||
| Sortino ratioReturn per unit of downside risk | -0.77 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.34 | -0.12 |
| Calmar ratioReturn relative to maximum drawdown | 1.91 | 3.05 | -1.14 |
| Martin ratioReturn relative to average drawdown | 5.05 | 7.90 | -2.85 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| AZN | DXT.TO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.15 | 1.91 | -0.76 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.50 | 0.66 | -0.17 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.64 | 0.15 | +0.49 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.50 | -0.01 | +0.51 |
Drawdowns
AZN vs. DXT.TO - Drawdown Comparison
The maximum AZN drawdown since its inception was -48.94%, smaller than the maximum DXT.TO drawdown of -97.83%. Use the drawdown chart below to compare losses from any high point for AZN and DXT.TO.
Loading charts...
Drawdown Indicators
| AZN | DXT.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.94% | -97.83% | +48.89% |
Max Drawdown (1Y)Largest decline over 1 year | -15.43% | -16.00% | +0.57% |
Max Drawdown (3Y)Largest decline over 3 years | -27.87% | -16.00% | -11.87% |
Max Drawdown (5Y)Largest decline over 5 years | -27.87% | -49.64% | +21.77% |
Max Drawdown (10Y)Largest decline over 10 years | -27.87% | -92.39% | +64.52% |
Current DrawdownCurrent decline from peak | -12.00% | -71.16% | +59.16% |
Average DrawdownAverage peak-to-trough decline | -11.37% | -62.09% | +50.72% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.80% | 6.16% | -0.36% |
Volatility
AZN vs. DXT.TO - Volatility Comparison
AstraZeneca PLC (AZN) has a higher volatility of 7.49% compared to Dexterra Group Inc. (DXT.TO) at 5.61%. This indicates that AZN's price experiences larger fluctuations and is considered to be riskier than DXT.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AZN | DXT.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.49% | 5.61% | +1.88% |
Volatility (6M)Calculated over the trailing 6-month period | 17.47% | 19.06% | -1.59% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.51% | 25.57% | -0.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.00% | 28.46% | -4.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.91% | 44.66% | -19.75% |
Dividends
AZN vs. DXT.TO - Dividend Comparison
AZN's dividend yield for the trailing twelve months is around 2.90%, less than DXT.TO's 2.98% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AZN AstraZeneca PLC | 2.90% | 1.70% | 2.27% | 2.15% | 2.12% | 2.35% | 2.80% | 2.81% | 3.69% | 3.95% | 5.01% | 4.06% |
DXT.TO Dexterra Group Inc. | 2.98% | 3.22% | 4.49% | 6.08% | 6.35% | 3.78% | 2.31% | 1.30% | 0.89% | 1.04% | 0.82% | 2.48% |
Financials
AZN vs. DXT.TO - Financials Comparison
This section allows you to compare key financial metrics between AstraZeneca PLC and Dexterra Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AZN vs. DXT.TO - Profitability Comparison
AZN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a gross profit of 12.61B and revenue of 15.29B. Therefore, the gross margin over that period was 82.5%.
DXT.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Dexterra Group Inc. reported a gross profit of 38.52M and revenue of 275.47M. Therefore, the gross margin over that period was 14.0%.
AZN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported an operating income of 4.25B and revenue of 15.29B, resulting in an operating margin of 27.8%.
DXT.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Dexterra Group Inc. reported an operating income of 15.71M and revenue of 275.47M, resulting in an operating margin of 5.7%.
AZN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a net income of 3.08B and revenue of 15.29B, resulting in a net margin of 20.2%.
DXT.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Dexterra Group Inc. reported a net income of 13.52M and revenue of 275.47M, resulting in a net margin of 4.9%.
Frequently Asked Questions
AZN and DXT.TO have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for AZN and DXT.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer